Trombopag 25 mg Tablet
20,40$
16,64$
Trombopag 25 mg tablet is a specialized medication classified as a thrombopoietin receptor agonist, primarily designed to address low platelet counts in patients with chronic immune thrombocytopenic purpura (ITP), severe aplastic anemia, and those suffering from chronic hepatitis C virus (HCV) infection. By stimulating the bone marrow, Trombopag enhances platelet production, effectively increasing the quantity of platelets in the bloodstream, which is crucial for proper blood clotting and overall health. It's important to monitor patients on Trombopag for potential liver function changes and to discuss any pre-existing conditions or medications with a healthcare provider to avoid adverse interactions. This medication should be used under strict medical supervision, as it may not be suitable for everyone, particularly those with certain liver conditions or those who are pregnant. Trombopag provides a vital therapeutic option for individuals facing the challenges of low platelet levels, contributing to improved health outcomes. Always follow your healthcare provider's instructions regarding dosage and duration of treatment to maximize effectiveness and safety. With its ability to promote platelet generation, Trombopag plays a significant role in managing serious blood disorders, offering hope to many patients.
Quantité
Active Pharmaceutical Ingredient
Uses
• Trombopag 25 mg tablet is primarily utilized for adult patients diagnosed with primary immune thrombocytopenia (ITP). This condition is characterized by a low platelet count, leading to symptoms like easy bruising and prolonged bleeding. Trombopag helps increase platelet production, thus addressing the underlying issues associated with ITP. Patients who have not found relief from other treatments may benefit significantly from this medication.
• In cases where traditional therapies such as corticosteroids and immunoglobulins have proven ineffective, Trombopag 25 mg tablet offers an alternative treatment option. By stimulating the bone marrow to produce more platelets, it helps mitigate the risks associated with low platelet levels. This can be particularly important for patients experiencing spontaneous bleeding or bleeding from mucous membranes. The use of Trombopag provides a new avenue for those struggling with persistent symptoms.
• Trombopag 25 mg tablet is also indicated for patients requiring a more effective management strategy for their ITP. The medication works by enhancing the body’s ability to generate platelets, which can lead to a reduction in bleeding incidents. This is crucial for maintaining a better quality of life for patients affected by this condition. Regular use of Trombopag may empower patients to engage more fully in their daily activities without the fear of bleeding complications.
• For individuals with ITP who are looking for a reliable treatment option, Trombopag 25 mg tablet represents a significant advancement. It is especially beneficial for those who have faced challenges with previous therapies and are in need of a more effective solution. By increasing platelet counts, Trombopag can help restore normal function and reduce the frequency of bleeding episodes. As a result, it plays an essential role in the comprehensive management of primary immune thrombocytopenia.
Benefits
In Low platelet count due to immune thrombocytopenia (ITP) or HCV infection: Trombopag Tablet is used to adults and children aged 1 year and above to increase the number of platelets, which aid in blood clotting, and minimize the risk of bleeding. This is particularly beneficial in chronic idiopathic thrombocytopenic purpura (ITP), a persistent condition that may cause unusual bruising or bleeding due to an abnormally low count of platelets in the blood. Trombopag 25 mg is used for patients who have not experienced any improvement or are unable to undergo other treatments, such as medication or splenectomy. Additionally, Trombopag 25 mg Tablet is used to increase the number of platelets in individuals who have hepatitis C, a viral infection that may impair liver function. It is usually administered concurrently with other medications.
Treatment of Severe Aplastic Anemia: Anti-thrombocytopenia Drug Trombopagis also used in combination with other medications to treat aplastic anaemia, a condition in which the body does not make enough new blood cells, in adults and children 2 years of age and above. Take it as advised by the doctor to get the most benefits.
Side Effects
Many medications, Trombopag 25 mg Tablet can cause side effects, but most of them are temporary and go away as the body adjusts to the medicine. However, if the side effects persist or worsen, or if you are concerned about them, it is important to consult your doctor.
Most Common Side Effects
• Headache
• Anaemia (low red blood cell counts)
• Decreased appetite
• Insomnia (difficulty sleeping)
• Cough
• Nausea (feeling sick)
• Diarrhoea
• Pruritus (itching)
• Alopecia (hair loss)
• Myalgia (muscle pain)
• Pyrexia (fever)
• Fatigue (tiredness)
Common Side Effects
• Asthenia (weakness)
• Chills
• Peripheral oedema
• Dizziness
• Dyspnoea (difficulty breathing)
• Pain in the belly or in the mouth and throat
• Joint pain
• Muscle spasms
• Pain in limbs
How To Use
Trombopag 25 mg Tablet can be taken on an empty stomach (1 hour before or 2 hours after a meal). It is better to take it, in the same way, and at the same time every day to get the maximum benefit. The dose depends on your weight, medical condition, and what you are being treated for. Your doctor will plan the correct dose for you. Do not stop taking the medication without consulting your doctor, even if you start to feel better. If you miss a dose, take it as soon as you remember. However, if it is close to the time of your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.
Safety Advice
• Alcohol: It is not recommended to consume alcohol while taking Trombopag 25 mg. Alcohol may increase the risk of side effects or interfere with the effectiveness of the Trombopag Tablet. It is best to talk to your doctor or pharmacist before consuming alcohol while taking any medicine.
• Kidney: Trombopag Tablet is safe to use in patients with kidney disease. No dose adjustment of Trombopag 25 mg is recommended. If you experience any side effects please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Trombopag 25 mg Tablet. {Product_name+_three} may pass into breast milk and harm the infant. If you are breastfeeding and taking Trombopag 25 mg Tablet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Trombopag 25 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Eltrombopag 25 mg Tablet and report any unusual symptoms or changes in liver function to their doctor. The dose of Eltrombopag 25 mg Tablet may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Trombopag 25 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Anti-thrombocytopenia Drug Trombopag during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Trombopag 25 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Anti-thrombocytopenia Drug Trombopag.